Keyword "RAPITALAM" found in the following publications:

NOVEL MGLUR4 AGONIST RAPITALAM AMELIORATES MOTOR DYSFUNCTION IN MICE WITH TAU-ASSOCIATED NEURODEGENERATION
&NBSP;
Introduction: Tau protein is classically involved in the pathogenesis of a neurodegenerative processes, such as Parkinson’s disease. This study was ...
Abstract | Full text (PDF)
ASSESSMENT OF THE DNA DAMAGE LEVEL IN PERIPHERAL BLOOD LEUKOCYTES OF MICE TREATED ORALLY WITH RAPITALAM IN ACUTE AND THERAPEUTIC DOSES
Rapitalam is a drug that is a modulator of the mglur4 receptor - a kind of metabotropic glutamate receptors. Into ...
Abstract | Full text (PDF)
PHARMACOKINETIC STUDIES OF NEW ANTIPARKINSONIAN DRUG RAPITALAM
Parkinson's disease is the most common neurodegenerative disorder after Alzheimer's disease. The aim of this study was to investigate the ...
Abstract | Full text (PDF)

Research Results in Biomedicine is included in the scientific database of the RINTs (license agreement No. 765-12/2014 dated 08.12.2014).

The journal is included in the list of peer-reviewed scientific publications recommended by the Higher Attestation Commission

The journal is indexed by the following scientific databases and platforms

Research Results in Biomedicine (ISSN 2658-6533)

The journal materials and website are licensed under Creative Commons «Attribution» 4.0 International.

The Founder: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University"The Founder’s address: 85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

The Publisher: Federal State Autonomous Educational Institution of HigherEducation "Belgorod National Research University" The Founder’s address:85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

Editors Office: chief editor Mikhail I. Churnosov, e-mail: RR_MedPharm@bsu.edu.ru, phone: +7 (4722) 30-14-03.

Regulations on the Journal

Certificate

Have questions?
You can write to us:

✉ Content manager

✉ Site administration

✉ Executive Secretary